Current Edition

Upcoming Events

Advertisement

news

FDA clears use of Novo’s obesity drug to protect heart health

The Food and Drug Administration has expanded the label for Novo Nordisk’s fast-selling weight loss drug Wegovy following study results that proved the medicine can ...
Continue Reading →
news

SGS LABORATORY IN FAIRFIELD, NJ, USA DEMONSTRATES ITS COMMITMENT TO TESTING AND CALIBRATION EXCELLENCE WITH NEW ISO/IEC 17025:2017 CERTIFICATION

The world’s leading testing, inspection and certification company announced today that its Fairfield laboratory has earned its ISO/IEC 17025:2017 certification. ...
Continue Reading →
news

FogPharma pulls in $145M to support cancer drug research

Dive Brief: Cancer drug developer FogPharma has raised $145 million in fresh funding, the company revealed Friday, announcing a Series E round that will give a f...
Continue Reading →
news

CDC panel mulls changes to RSV vaccine recommendation

Advisers to the Centers for Disease Control and Prevention are weighing updates to their recommendation older adults get vaccinated for respiratory syncytial virus, ...
Continue Reading →
news

Gritstone to lay off 40% of workforce after costly study delay

Gritstone Bio will lay off about 40% of its workforce after missing out on funding it expected to receive this quarter, the company said Thursday. Gritstone, a ma...
Continue Reading →
news

Cure Ventures backs a cell therapy startup targeting Parkinson’s

Kenai Therapeutics, a San Diego-based biotechnology company, has raised $82 million to support its work developing cell therapies for nervous system disorders. Cu...
Continue Reading →
news

Moderna pitches RSV shot, new vaccines after ‘difficult year of transition’

Dive Brief: Moderna shares rose by as much as 10% Thursday morning after the COVID-19 vaccine developer reported fourth quarter profit that beat Wall Street expe...
Continue Reading →
news

Frontier gets $80M, Galapagos’ backing to make a better KRAS drug

Biotechnology startup Frontier Medicines has pulled in $80 million in new funding to support a targeted cancer drug the company thinks might address some of the limi...
Continue Reading →
news

NEJM paper fills in details on ‘remarkable’ CAR-T result in autoimmune disease

A new research paper offers the most thorough look yet at a study that sparked the drug industry’s recent experimentation with cell therapy for autoimmune diseases. ...
Continue Reading →
news

AbbVie’s Cerevel deal hits an uncommon roadblock

AbbVie’s multibillion-dollar bid to acquire Cerevel Therapeutics has hit an unusual snag that could prevent the deal from closing for months. The companies said t...
Continue Reading →